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Platelet microbicidal proteins (PMPs) are small, cationic peptides which possess potent microbicidal
activities against common bloodstream pathogens, such as Staphylococcus aureus. We previously showed that
S. aureus strains exhibiting resistance to thrombin-induced PMP (tPMP-1) in vitro have an enhanced capacity
to cause human and experimental endocarditis (T. Wu, M. R. Yeaman, and A. S. Bayer, Antimicrob. Agents
Chemother. 38:729–732, 1994; A. S. Bayer et al., Antimicrob. Agents Chemother. 42:3169–3172, 1998; V. K.
Dhawan et al., Infect. Immun. 65:3293–3299, 1997). However, the mechanisms mediating tPMP-1 resistance in
S. aureus are not fully delineated. The S. aureus cell membrane appears to be a principal target for the action
of tPMP-1. To gain insight into the basis of tPMP-1 resistance, we compared several parameters of membrane
structure and function in three tPMP-1-resistant (tPMP-1r) strains and their genetically related, tPMP-1-
susceptible (tPMP-1s) counterpart strains. The tPMP-1r strains were derived by three distinct methods:
transposon mutagenesis, serial passage in the presence of tPMP-1 in vitro, or carriage of a naturally occurring
multiresistance plasmid (pSK1). All tPMP-1r strains were found to possess elevated levels of longer-chain,
unsaturated membrane lipids, in comparison to their tPMP-1s counterparts. This was reflected in correspond-
ing differences in cell membrane fluidity in the strain pairs, with tPMP-1r strains exhibiting significantly
higher degrees of fluidity as assessed by fluorescence polarization. These data provide further support for the
concept that specific alterations in the cytoplasmic membrane of S. aureus strains are associated with tPMP-1
resistance in vitro.
Staphylococcus aureus is a major human pathogen, both in
community- and nosocomially acquired infections (3, 9, 10, 27).
Our laboratories and others have characterized an array of
cationic, antimicrobial peptides from mammalian platelets,
termed platelet microbicidal proteins (PMPs) (4, 45, 46).
Among these is thrombin-induced PMP-1 (tPMP-1) which is
released from platelets stimulated with thrombin (46, 47).
This peptide exerts potent microbicidal effects in vitro against
pathogens that commonly gain access to the bloodstream, in-
cluding S. aureus (43). The antimicrobial host defense func-
tions of platelets against endovascular infections like endocar-
ditis have been proposed to result from, in part, their capacity
to release tPMP-1 in response to physiological stimuli gener-
ated at damaged endovascular surfaces. Since the isolation of
organisms such as S. aureus from the bloodstream of patients is
relatively common (10, 27) yet S. aureus endocarditis is com-
paratively uncommon (10), it is likely that tPMP-1 plays a key
role in preventing such endovascular infections. Implicit in
this notion is an intrinsic susceptibility of the pathogen to the
antimicrobial effects of tPMP-1. In contrast, tPMP-1-resistant
(tPMP-1r) organisms may have a distinct survival advantage at
sites of endovascular damage. Our laboratories have recently
confirmed that tPMP-1r strains of S. aureus exhibit an en-
hanced propensity to induce both human and experimental
endocarditis (1, 5, 6) and are associated with a more severe
form of this infection compared to tPMP-1-susceptible (tPMP-
1s) counterpart strains (5, 6).
Our previous studies have identified the S. aureus cytoplas-
mic membrane as a principal target for the microbicidal actions
of PMPs, leading to rapid depolarization, permeabilization,
and eventual cell death (14). The cytoplasmic membranes of
tPMP-1r strains of S. aureus appeared to be more resistant to
these perturbations than genetically related tPMP-1s counter-
part strains (14, 45; T. M. Wu, M. R. Yeaman, C. C. Nast, C.
Itatani, and A. S. Bayer, Abstr. 96th Gen. Meet. Am. Soc.
Microbiol. 1996, abstr. A72, 1996). These data suggest that one
mechanism of tPMP-1 resistance in S. aureus relates to alter-
ations in cytoplasmic membrane structure and/or function.
As noted above, thrombin, a key platelet agonist generated
at sites of endothelial cell damage or microbial colonization
(7, 44) prompts the release of antimicrobial peptides (tPMPs)
from rabbit and human platelets (40, 47). As shown by acid-
urea gel electrophoresis and reverse-phase high-performance
liquid chromatography, the predominant tPMP released by
thrombin from rabbit platelets is tPMP-1 (46, 47). The present
study was designed to compare the membrane characteristics
of genetically related strains of S. aureus exhibiting tPMP-1s or
tPMP-1r phenotypes in vitro.
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(This study was presented in part at the 97th General Meet-
ing of the American Society for Microbiology, Miami Beach,
Fla., May 1997 [abstr. 2539].)
MATERIALS AND METHODS
Bacterial strains. The S. aureus strains used in this study are described in
Table 1. The detailed methods for the in vitro susceptibility testing of strains
against tPMP-1 have been previously reported (6, 17, 48). ISP479 is a tPMP-1s
strain that carries plasmid pI258, which encodes resistance to cadmium and
ampicillin (6). This plasmid also contains the transposon, Tn551, which confers
erythromycin resistance. ISP479C is a well-characterized, tPMP-1s strain that is
the spontaneous, plasmid-cured variant of ISP479 (6). ISP479R is a transposon
mutant of ISP479 that exhibits stable tPMP-1 resistance in vitro (6). This strain
contains a single Tn551 chromosomal insert (6). Extensive phenotypic and ge-
notypic analyses reveal no detectable differences between these two strains (6).
Strain 19S, a clinical isolate, is tPMP-1s in vitro; strain 19R is a stable tPMP-1r
variant of 19S selected after serial in vitro passage in the presence of tPMP-1
(48). Strains 19S and 19R are indistinguishable in colonial morphologies, bio-
chemical and antibiogram comparisons, protein A or clumping factor expression,
cell wall protein immunoblot profiles, coagulase or b-lactamase secretion, and
genotypic characteristics (pulse-field gel electrophoretograms) (48). SK982 is a
well-characterized tPMP-1s strain (17, 19). SK2355 contains the 28.1-kb multi-
resistance plasmid, pSK1, that encodes dfrA-mediated trimethoprim resistance
(34), qacA-mediated resistance to multiple organic cations (21, 25, 33), and
aacA-aphD-directed aminoglycoside resistance (32). Additionally, recent studies
have shown that the qacA determinant on pSK1 confers in vitro resistance to
tPMP-1 (17). Thus, the above three strain pairs represent well-characterized,
tPMP-1s parental strains and tPMP-1r counterpart strains derived by distinct
strategies: transposon mutagenesis, in vitro passage in tPMP-1, and plasmid
carriage.
Assessment of hydrophobicity. S. aureus surface hydrophobicities were deter-
mined using a dual-phase partitioning technique (38), employing the immiscible
phases, polyethylene glycol (PEG) (hydrophobic phase), and dextran (hydrophil-
ic phase). Previous studies have demonstrated a direct relationship between PEG
affinity and cell hydrophobicity (38). One milliliter each of PEG (molecular
weight, 6,000; 120 g/liter) and dextran (molecular weight, 37,000; 160 g/liter)
(both from Sigma Co., St. Louis, Mo.) was added to glass cuvettes. Bacteria were
grown overnight on brain-heart infusion agar (Difco, Detroit, Mich.), harvested
from plates, washed, and adjusted in phosphate-buffered saline to a final inoc-
ulum of 108 CFU/ml. For each strain, 1 ml of the bacterial suspension was added
to 1 ml of the biphasic system, and the tubes were vigorously vortexed and then
held stationary at 22°C for 2 h for phase separation. Then, 100 ml was carefully
sampled from each phase and quantitatively cultured. The hydrophobicity index
was expressed as the percentage of the total bacterial inoculum recovered from
the PEG phase.
Lipid extraction. Bacterial cells were grown to mid-log phase (optical density
at 650 nm [OD650] 5 0.6), centrifuged, washed twice in double-distilled water,
and sonicated. Sonicated cells were then mixed with 15 to 20 volumes of chlo-
roform-methanol (2:1, vol/vol), and the suspension was stirred for 2 h at 30°C.
The resulting extract was filtered through Whatman filter paper (no. 1), and the
extraction procedure was repeated with the residual cell material. The extracts
were pooled and washed with 0.2 vol of 0.9% NaCl to remove nonlipid contam-
inants. The clear, lipid-containing lower phase was removed, evaporated to
dryness under a nitrogen atmosphere at 45°C, and stored at 220°C until analysis.
Resolution, identification, and quantitation of phospholipids. Phospholipids
were separated by two-dimensional thin-layer chromatography using Silica Gel G
as an adsorbent matrix (0.44 mm thick) and the following solvent system: solvent
I (chloroform-methanol–30% ammonium hydroxide [65:30:4, vol/vol/vol]) and
solvent II (chloroform-methanol-acetic acid-water [170:25:25:4, vol/vol]). The
resolved phospholipids were visualized by exposure to iodine vapor and identi-
fied by comparison with internal phospholipid standards.
Isolated phospholipids were individually excised from chromatographic gels,
and digested at 180°C with 1 ml of 60% perchloric acid for 2 h. The digested
samples were incubated with 10 ml of chromatic developer (10% ascorbic acid–
2.5% ammonium molybdate–4% perchloric acid [1:1:8, vol/vol/vol]) at 30°C for
2 h. Color intensity was measured at OD660 and used to quantify the amount of
each phospholipid compared to a standard generated from known amounts of
that specific phospholipid (37, 39). The phospholipid species analyzed were:
phosphatidylinositol, phosphatidylserine, phosphatidylethanolamine, phosphati-
dylglycerol, cardiolipin, and phosphatidic acid.
Fatty acid extraction and characterization. Fatty acid extractions, methyl ester
derivatizations, and their separation were essentially done as previously de-
scribed (20). In brief, washed bacterial cells were suspended in 10 ml of 1 M
alkaline ethanol (KOH) (90% ethanol, vol/vol). Saponification of lipids was
achieved by refluxing the suspension for 2 to 3 h at 90°C, after which it was
filtered through Whatman filter paper (no. 1). The residue was then washed with
ethanolic KOH (10 ml) and transferred to a conical flask containing 30 ml of
water. The solution was acidified with 6 N HCl (3.5 ml), and the fatty acids were
extracted by shaking with 2 ml of chloroform for 30 min. The chloroform extracts
were recovered and evaporated to dryness under a nitrogen stream.
Fatty acid methyl esters were prepared using thionyl chloride. Extracted fatty
acids were dissolved in 5 ml of chloroform-methanol (3:7, vol/vol); 0.2 to 0.3 ml
of thionyl chloride was then added with constant stirring at 4°C. After thorough
mixing, the reaction was continued for 2 h to ensure complete conversion of fatty
acids to their respective methyl ester derivatives. Double-distilled water (5 ml)
was added to extract hydrophilic components and provide phase separation. The
hydrophobic phase was washed four to five times with distilled water to remove
residual thionyl chloride. The chloroform extract was then dried under nitrogen,
and samples were stored at 220°C until used.
Derivatized fatty acids were analyzed by gas-liquid chromatography on a 2 M
(10%) diethylene glycol succinate column (supported on a 100/200-mesh di-
atomic at 180°C). A Shimadzu (Tokyo, Japan) GC9A instrument equipped with
a flame ionization detector was used for these analyses. The injection port was
maintained at 210°C, and the carrier gas (nitrogen) flow rate was maintained at
40 ml/min. Methyl esters of specific fatty acids were identified by comparing their
retention times to those of authentic internal standards and were quantified by
a Chromatopac CR2A automated integrator using area normalization methods.
Characterization of membrane fluidity through unsaturation indices. The
unsaturation index for each tPMP-1s and tPMP-1r strain pair was derived from
the overall distributions of monounsaturated and polyunsaturated membrane
fatty acids (as determined above), using the formula of Stubbs and Smith (39).
The molar unsaturation index was defined as 1(% monoenes)/100 1 2(%
dienes)/100 1 3(% trienes)/100, where % monoenes represents the percentage
of monounsaturated fatty acid, % dienes represents the percentage of di-unsat-
urated fatty acids, and % trienes represents the percentage of tri-unsaturated
fatty acids. Previous studies have proven that a higher unsaturation index directly
relates to a more fluid membrane (39).
Membrane fluidity was also quantified by the relative distribution and three-
dimensional orientation of fluorescent dyes within the lipid layers. In brief, a
whole-cell suspension of each bacterial strain was prepared with a bacterial
density of ;109 CFU/ml. This suspension was pelleted by centrifugation (5,000 3
g for 15 min) and then resuspended in digestion buffer (20% [wt/vol] sucrose,
0.05 Tris-HCl, 0.145 M NaCl [pH 7.6]). The bacterial cell wall was then digested
with lysostaphin (34 mg/ml; Applied Microbiology, Tarrytown, N.Y.) in the pres-
ence of DNase I (16 mg/ml; Boehringer Mannheim, San Diego, Calif.) for 1 h at
37°C (14). The sucrose-stabilized protoplasts were collected by centrifugation
(10,000 rpm for 15 min) and resuspended in fresh digestion buffer. The adequacy
of cell wall digestion was confirmed by Gram staining to ensure that the prep-
aration consisted of gram-negative, spherical protoplasts rather than gram-pos-
itive cocci. All protoplast preparations were held at room temperature and used
within 24 h of preparation. For these studies, stable, cell wall-free staphylococcal
protoplasts (prepared as previously described [14]) were labeled with two distinct
fluorescent dyes. Protoplasts were labeled with either 1,6-diphenyl-1,3,5-hexatri-
ane (DPH) or 1-anilino-8-naphthalene sulfonate (ANS) (Sigma) (11, 37). DPH
specifically labels and fluoresces within the hydrophobic regions of the lipid
bilayer (11) but lacks fluorescence in aqueous environments. The steady-state
fluorescence of the DPH probe predominantly reflects the structural order of
membrane lipids, mainly as a result of preferential partitioning of the probe into
the hydrocarbon phase of the lipid membrane bilayer when it is in a fluid state
(11, 37). Thus, membrane fluidity may be considered the reciprocal of the
structured order of membrane lipids. In contrast, ANS is a hydrophilic label that
is used to monitor polar head regions. Thus, the two probes localize in distinct
domains of the lipid bilayer, giving different absolute fluorescence polarization
values related to polar head regions or hydrophobic cores.
For DPH labeling, a 2 mM solution of this dye was prepared in tetrahydro-
furan, and 100 ml was added to 50 ml of agitated 0.05 M Tris-HCl (pH 7.6).
Excess tetrahydrofuran was removed by flushing with nitrogen. Protoplasts sus-
pended in digestion buffer were then incubated in either DPH (final concentra-
tion 5 2 mM) or ANS (final concentration 5 33.3 mM) for 60 min at 30°C.
Fluorescence polarization was measured using a Kontron spectrofluorometer
(Copenhagen, Denmark). Excitation of fluorescent probes was accomplished
with vertically polarized monochromatic light at 360 nm for DPH or 350 nm for
ANS. Emission intensity was quantified at 426 nm for DPH or 496 nm for ANS
TABLE 1. S. aureus strains used in this study
Strain Descriptiona Reference
ISP479 Strain carrying pI258, which contains
Tn551; tPMP-1s
6
ISP479C Plasmid-cured derivative of ISP479;
tPMP-1s
6
ISP479R Tn551 mutant of ISP479; tPMP-1r 6
19S Clinical bloodstream isolate; tPMP-1s 48
19R Passage derivative of 19S; tPMP-1r 48
SK982 Parental strain; tPMP-1s 17, 19
SK2355 SK982 carrying pSK1; tPMP-1r 17, 25, 32–34
a A strain is defined as tPMP-1r if $40% survival of a 2 3 103 inoculum is
determined after exposure in vitro to tPMP-1 (2 mg/ml) for 2 h (1).
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using a detector oriented either parallel or perpendicular to the direction of the
polarized excitation source. The degree of fluorescence polarization or polariza-
tion index (p) was calculated from the following formula (11, 37): p 5 [IV 2 IH
(IHV/IHH)]/IV 1 IH (IHV/IHH). In this formula, I is the corrected fluorescence
intensity, subscripts V and H indicate the values obtained with vertical or hori-
zontal orientation of the analyzer, respectively. The corrected fluorescence was
determined by subtraction of unlabeled control protoplast emissions from those
of labeled protoplasts. The lower the fluorescence polarization value, the higher
the degree of membrane fluidity.
Amino acid transport. S. aureus strains were grown in brain heart infusion
broth to mid-logarithmic phase of growth (OD650 5 0.6), pelleted by centrifu-
gation, washed, and resuspended as a 10% (wt/vol) cell suspension in ultrapure
water (MilliQ water; Millipore). The bacterial cell suspension was incubated at
30°C for 10 min in 100 mM Tris-citrate (pH 4.5) containing chloramphenicol
(200 mg/ml) to inhibit protein synthesis. Amino acid uptake studies were then
initiated by the addition of one of the following: 14C-labeled amino acids (final
concentration, 100 mM; Sigma) L-glutamic acid, L-lysine, or L-alanine (74 kBq/
mol 5 2 mCi/mol). Aliquots of 100 ml were sampled from this reaction mixture
every 45 s up to 180 s and diluted into 3 ml of ice-cold wash buffer (10 mM
Tris-citrate, pH 4.5) containing the respective unlabeled amino acid at the same
concentrations as their labeled counterparts. These aliquots were rapidly passed
through membrane filters (0.45-mm pore size; Millipore), and the filters then
washed twice with buffer. The filters were dried at 65°C, and the radioactivity
retained was counted in a Beckman LS 1801 liquid scintillation beta counter. The
rates of amino acid uptake were calculated over the 180-s sampling period using
linear regression analysis as described by Rao et al. (31), and are expressed as
nanomoles per milligram (dry weight) of cell.
STATISTICAL ANALYSES
The fluorescence polarization indices were compared for each strain pair by
Student’s t test for unpaired samples, employing the statistical package within
Sigma Plot (version 3.02). P values of #0.05 were considered significant.
RESULTS
Hydrophobicity studies. Many endogenous cationic micro-
bicidal peptides are amphipathic molecules exhibiting both
charged regions that promote avidity for the electronegative
characteristics of bacterial membranes and hydrophobic re-
gions that may facilitate insertion into and span target mem-
branes (8, 35). Therefore, it is conceivable that net bacterial
surface hydrophobicity influences the overall microbicidal ef-
fects of tPMP-1. However, there were no significant differences
in the hydrophobicity indices of the three tPMP-1s and
tPMP-1r strain pairs, with each member of a strain pair
exhibiting a hydrophobicity index similar to its counterpart
strain (data not shown).
Fatty acid composition. Compositions of cell membrane
fatty acids for each strain studied are summarized in Table 2.
Elevated levels of longer-chain, unsaturated fatty acid species
(determined by molar ratios) were noted in all three tPMP-1r
strains, in comparison to their tPMP-1s counterpart strains.
Indeed, in the tPMP-1r strain SK2355 there appears to be a
shift from smaller, saturated fatty acid species (exhibited by the
tPMP-1s parental strain, SK982) to larger, more polyunsatu-
rated species. Also, the membranes of the tPMP-1r strains
contained from approximately two- to sixfold more of the
triene, linolenic acid (an 18:3 fatty acid), than did the tPMP-1s
counterpart strains. Similarly, the membranes of the tPMP-1r
strain SK2355 (carrying pSK1), contained ;10-fold more of
the diene lipid, linoleic acid (an 18:2 fatty acid), than did its
plasmid-free, tPMP-1s counterpart, SK982. These findings are
consistent with a correlation between tPMP-1 resistance and
increases in fatty acid length and unsaturation.
Phospholipid composition. No substantive differences were
observed in the proportional phospholipid compositions of the
tPMP-1s and tPMP-1r strain pairs (data not shown). Although
there were differences in the proportions of specific phospho-
lipids between individual tPMP-1s and tPMP-1r strain pairs,
these changes were not uniform across all of the strain pairs.
For example, the proportion of phosphatidyl glycerol in the
tPMP-1r strain ISP479R was substantially larger than that in its
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tPMP-1s counterpart strain, ISP479C. However, the reverse
was true in the 19S-19R strain pair.
Membrane fluidity. Two methods were employed to ascer-
tain whether differences in membrane fluidity were associated
with tPMP-1s or tPMP-1r phenotypes in S. aureus strains: de-
termination of unsaturation indices and fluorescence polariza-
tion. As noted in Table 3, by the DPH assay, the degree of
membrane fluidity was uniformly and significantly higher for
all three tPMP-1r S. aureus strains than for their tPMP-1s
parental strains. Data generated with the other fluorescent
membrane probe, ANS, also confirmed a higher degree of
membrane fluidity in tPMP-1r strains than in tPMP-1s coun-
terpart strains (data not shown). However, these differences
did not reach statistical significance (0.05 , P ,0.10).
There was a trend towards higher calculated lipid unsatura-
tion indices for tPMP-1r strains compared to those calculated
for their respective tPMP-1s counterparts; this potentially re-
flects the shift towards higher proportions of polyunsaturated
fatty acids in the tPMP-1r strains (Table 2). However, this
trend did not reach statistical significance.
Amino acid transport. The extent and rates of uptake of
selected amino acids were assessed as additional comparative
measures of cytoplasmic membrane function in tPMP-1s and
tPMP-1r strain pairs. A panel of amino acids including L-lysine
(cationic), L-glutamic acid (anionic), and L-alanine (neutral,
hydrophobic) was selected, since each amino acid has a distinct
membrane transporter. Substantial differences in uptake pro-
files of these amino acids between the individual tPMP-1s and
tPMP-1r strain pairs were observed. However, there were no
uniform variances in transport profiles among the tPMP-1s and
tPMP-1r strain pairs studied (data not shown). For example,
in tPMP-1r ISP479R, amino acid uptake was substantially
lower than that seen in the corresponding tPMP-1s strain,
ISP479C. In contrast, in strain pair 19S-19R, although the
glutamic acid and lysine uptake profiles differed between the
two strains, these differences were inversely related to those
seen in the ISP479C-ISP479R strain pair (i.e., lowered rates
of uptake by tPMP-1s strains). Thus, no amino acid trans-
port characteristics were consistently associated with tPMP-1
resistance in vitro.
DISCUSSION
Cationic antimicrobial peptides are believed to target the
cell membrane of microbial pathogens to initiate their lethal
effects (2, 8, 22, 35). We have recently demonstrated that the
cytoplasmic membrane of S. aureus is, indeed, a principal tar-
get for the microbicidal actions of tPMP-1. This conclusion
emanates from multiple lines of evidence, including (i) elec-
trophysiological studies using artificial planar lipid bilayers (13,
14), (ii) transmission electron microscopic investigations of the
ultrastructural effects of tPMP-1 upon whole S. aureus cells
and cell wall-free protoplasts (14; Wu et al., Abstr. 96th Gen.
Meet. Am. Soc. Microbiol. 1996), and (iii) flow cytometry
studies of tPMP-1-induced cytoplasmic membrane permeabi-
lization (45).
Using planar lipid bilayers to model bacterial membranes in
vitro, we have recently shown that tPMP-1 permeabilizes and
disrupts such membranes in a manner that is influenced by
peptide concentration and orientation of transmembrane volt-
age orientation (13). The membrane permeabilization effects
of tPMP-1 were consistently enhanced in the trans-negative
orientation, mirroring the voltage polarity of bacterial cyto-
plasmic membranes (13, 14). These data paralleled in vitro
microbicidal data in which S. aureus cells defective in the gen-
eration of a threshold trans-negative membrane electrical
gradient (gradient , 2100 mV) were relatively resistant to
the lethal actions of tPMP-1 (12; A. S. Bayer, M. R. Yeaman,
H.-G. Sahl, D. Brar, and R. A. Proctor Abstr. 97th Gen. Meet.
Am. Soc. Microbiol, abstr. A–106, 1997). Ultrastructurally,
tPMP-1 induces rapid perturbations of the cytoplasmic mem-
branes of whole S. aureus cells in tPMP-1s strains, which pre-
cedes cell lysis or death (45). Additionally, protoplasts derived
from tPMP-1s strains (but not from tPMP-1r strains) are rap-
idly lysed in the presence of tPMP-1, coincident with ultra-
structural disruption of the cytoplasmic membrane as demon-
strated by transmission electron microscopy (14). Furthermore,
flow cytometry analyses have shown that exposure of tPMP-1s
(but not tPMP-1r) whole S. aureus cells to tPMP-1 leads to
rapid uptake of a small (2 nm) fluorescent probe (propidium
iodide) without depolarization of the cytoplasmic membrane
(45). Thus, phenotypic resistance to tPMP-1 in vitro correlates
with relative refractoriness to peptide-induced cytoplasmic
membrane permeabilization (14, 45). Collectively, this body of
data underscores the likely importance of the bacterial cyto-
plasmic membrane as a proximate target of the microbicidal
actions of tPMP-1.
The current study sought to identify membrane characteris-
tics in S. aureus that may account for susceptibility or resistance
to the in vitro microbicidal actions of tPMP-1. To maximize the
power of our studies, we employed three distinct S. aureus
strain pairs of differing genetic lineages in which tPMP-1 re-
sistance was induced via different mechanisms: transposon mu-
tagenesis (6), serial passage (48), or plasmid carriage (17, 21,
41). Despite these differing modes of induction of tPMP-1 re-
sistance in vitro, several themes emerged from these studies
relative to membrane alterations in tPMP-1s vs tPMP-1r strains.
Membranes composed predominantly of saturated fatty ac-
ids tend to be relatively rigid. In contrast, polyunsaturated fatty
acids possess multiple, restrictive double bonds which promote
lipid disorder, translating into increased membrane fluidity
(29, 42). In each of the three tPMP-1r strains studied, there was
a substantial shift in fatty acid content toward a predominance
of polyunsaturated species. Of interest, the presence of specific
polyunsaturated fatty acids in tPMP-1r strains differed among
the strain pairs as determined by unsaturation indices (11, 37,
39). Furthermore, fluorescence polarization demonstrated that
the cytoplasmic membranes of the tPMP-1r strains were more
fluid than their tPMP-1s counterpart strains. These data may
provide important insights for future investigations into defin-
ing the mechanistic basis of tPMP-1 resistance in S. aureus,
vis-a`-vis the relationship of tPMP-1 resistance to membrane
fluidity.
Analysis of the transport characteristics of either cationic,
TABLE 3. Membrane fluidity of tPMP-1s and tPMP-1r
S. aureus strains
Strains Fluorescence polarizationa Unsaturation indexb (mole21)
19S 0.022 6 0.007 0.60 6 0.09
19R 0.003 6 0.001c 0.75 6 0.09
ISP479C 0.021 6 0.006 0.620 6 0.02
ISP479R 0.001 6 0.01d 0.632 6 0.03
SK982 0.023 6 0.01 0.17 6 0.015
SK2355 0.007 6 0.001c 0.382 6 0.002
a These data represent the means 6 standard deviations of 10 independent
runs with DPH (measured in fluorescence units).
b Unsaturation index 5 1 (% monoene)/100 1 2 (% diene)/100 1 3 (%
triene)/100 of two independent determinations (means 6 standard deviations).
c P 5 0.002 (for comparisons between strains 19S and 19R and strains SK982
and SK2355).
d P 5 0.00004 (for comparison between strains ISP479C and ISP479R).
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anionic, or neutrally charged amino acids within individual
strain pairs disclosed that substantial differences in uptake
profiles are present between the tPMP-1r and tPMPs strains.
However, there were no consistent defects in the uptake of
individual amino acids observed for all tPMP-1r strains. Each
amino acid tested in this study utilizes a specific membrane
transport system (28, 31). Therefore, it is likely that the differ-
ences observed in uptake profiles of tPMPs and tPMPr strains
were related to global alterations in the cytoplasmic mem-
branes of resistant strains rather than to alterations of any one
specific uptake system. In this regard, Lunbaek et al. (18),
using both planar lipid bilayers and tissue culture monolayers,
showed that membrane protein function is markedly affected
by artificially varying the degrees of membrane rigidity.
The precise relationships between increased membrane flu-
idity and tPMP-1 resistance are under investigation. Of inter-
est, fluconazole-resistant Candida albicans strains exhibit alter-
ations in membrane lipid composition, membrane fluidity, and
amino acid uptake similar to those which we have demon-
strated for tPMP-1r S. aureus strains (R. Prasad, J. Chandra, A.
Koul, P. Belanger, H. Sanati, and M. Ghannoum, Abstr. 96th
Gen. Meet. Am. Soc. Microbiol. 1996, abstr. F-74, 1996). Such
Candida strains have been shown to possess an energy-depen-
dent drug efflux mechanism, putatively analogous to the mul-
tidrug resistance efflux pumps of mammalian tumor cells (15,
16, 24, 30). Likewise, there are at least two examples of energy-
dependent systems conferring a cationic peptide-resistant phe-
notype in bacterial species. Peschel et al. and Otto et al. (23,
26) have studied the lantibiotics epidermin and gallidermin,
which are lanthionine-containing peptides isolated from Staph-
ylococcus epidermidis. Strains possessing the lantibiotic resis-
tance gene complex, epiFEG, appear to extrude these peptides
from the target cytoplasmic membrane after initial attachment
but prior to transmembrane insertion, spanning and ensuing
microbicidal effects. Although this mechanism is energy depen-
dent and mediated by the ATP-binding cassette transporter,
EpiFEG, it does not appear to be a typical efflux system.
Additionally, Shafer et al. (36) have recently characterized the
gonococcal proton-motive force-dependent efflux pump, Mtr,
which confers resistance to a variety of structurally diverse, hy-
drophobic antimicrobial agents. Interestingly, this mechanism
also confers gonococcal resistance to protegrin-1, a cysteine-
rich, cationic antimicrobial peptide from porcine leukocytes.
In the context of the above observations on antimicrobial
peptide extrusion and efflux systems (23, 26, 36), it is tempting
to speculate that the qacA-encoded, proton motive force-de-
pendent cation efflux pump carried by plasmid pSK1 (21, 25)
confers tPMP-1 resistance (17) via efflux of the peptide. While
this may prove to be the case, the collective results for all three
tPMP-1r strains presented here, including that carrying qacA,
raise the possibility that resistance to this peptide can arise via
mechanisms that ultimately contribute to cytoplasmic mem-
brane disorder.
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